RT @_Castillo_Pedro: Infxn risk of 1st year on rituximab for mod to severe SLE vs standard-of-care ð¹Most common SoC R
Tweet Content
Infxn risk of 1st year on rituximab for mod to severe SLE vs standard-of-care
🔹Most common SoC Rx: MMF, Aza, and/or cyclophosphamide
🔹🚫significant diff
🔹RTX pts = ⬆️dz duration, ⬆️# of prior meds, ⬇️maintenance steroid dose
https://t.co/AYQFXqlubl
#ACR21 Abst1288 @RheumNow
Links
First Year Infection Risk in SLE Patients Treated with Rituximab versus Standar…
https://bit.ly/3BZvD2y
Show on Archive Page
On
Display in Search Results
On
PDQ
Off